We are live on ! Find out more
FC

FORA Capital Portfolio holdings

AUM $1.36B
1-Year Est. Return 56.1%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+56.1%
3 Year Est. Return
+119.91%
5 Year Est. Return
+163.37%
10 Year Est. Return
AUM
$827M
AUM Growth
+$261M
Cap. Flow
+$286M
Cap. Flow %
34.55%
Top 10 Hldgs %
16.11%
Holding
687
New
231
Increased
120
Reduced
60
Closed
276

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$16M
2
CRWV
CoreWeave
CRWV
+$14M
3
RBLX icon
Roblox
RBLX
+$12.4M
4
CAT icon
Caterpillar
CAT
+$12.3M
5
IREN icon
Iris Energy
IREN
+$11.5M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$12.4M
2
APP icon
Applovin
APP
+$12.1M
3
PLTR icon
Palantir
PLTR
+$9.92M
4
LULU icon
lululemon athletica
LULU
+$6.96M
5
KO icon
Coca-Cola
KO
+$5.99M

Sector Composition

Rank Sector Weight
1 Technology 25.79%
2 Financials 16.62%
3 Industrials 13.59%
4 Communication Services 10.97%
5 Healthcare 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDTX
151
DELISTED
Cidara Therapeutics
CDTX
$1.39M 0.17%
+6,277
New +$1.01M
ROIV icon
152
Roivant Sciences
ROIV
$25.2B
$1.39M 0.17%
+63,862
New +$1.26M
NTRA icon
153
Natera
NTRA
$37.5B
$1.38M 0.17%
+6,043
New +$1.26M
LLY icon
154
Eli Lilly
LLY
$1.07T
$1.38M 0.17%
1,288
-339
-21% -$324K
BMY icon
155
Bristol-Myers Squibb
BMY
$127B
$1.38M 0.17%
25,659
-1,867
-7% -$89.8K
ARGX icon
156
argenx
ARGX
$57.4B
$1.38M 0.17%
1,645
+1,027
+166% +$879K
SJM icon
157
J.M. Smucker
SJM
$12.6B
$1.38M 0.17%
12,842
+8,592
+202% +$888K
EXAS
158
DELISTED
Exact Sciences
EXAS
$1.38M 0.17%
13,615
+4,457
+49% +$358K
INSM icon
159
Insmed
INSM
$23.2B
$1.38M 0.17%
+7,942
New +$1.45M
ALNY icon
160
Alnylam Pharmaceuticals
ALNY
$36.3B
$1.38M 0.17%
3,466
+747
+27% +$331K
PEG icon
161
Public Service Enterprise Group
PEG
$39.8B
$1.38M 0.17%
17,136
+11,875
+226% +$969K
APGE icon
162
Apogee Therapeutics
APGE
$10.2B
$1.37M 0.17%
+18,200
New +$1.15M
RVMD icon
163
Revolution Medicines
RVMD
$40.2B
$1.37M 0.17%
17,357
+10,988
+173% +$720K
RNAM
164
DELISTED
Avidity Biosciences
RNAM
$1.37M 0.17%
+18,997
New +$1.23M
CRBG icon
165
Corebridge Financial
CRBG
$14.1B
$1.37M 0.17%
+45,406
New +$1.4M
TERN
166
DELISTED
Terns Pharmaceuticals
TERN
$1.36M 0.16%
+33,728
New +$779K
ABT icon
167
Abbott
ABT
$180B
$1.36M 0.16%
+11,065
New +$1.41M
IDCC icon
168
InterDigital
IDCC
$6.68B
$1.36M 0.16%
4,268
+2,671
+167% +$944K
NVO
169
Novo Nordisk
NVO
$216B
$1.35M 0.16%
19,726
-2,611
-12% -$134K
INSP icon
170
Inspire Medical Systems
INSP
$1.42B
$1.32M 0.16%
14,266
+5,338
+60% +$511K
CHD icon
171
Church & Dwight Co
CHD
$23.1B
$1.31M 0.16%
15,658
-6,117
-28% -$523K
ETN icon
172
Eaton
ETN
$157B
$1.29M 0.16%
+4,045
New +$1.43M
MEDP icon
173
Medpace
MEDP
$16.8B
$1.29M 0.16%
+2,291
New +$1.3M
DE icon
174
Deere & Co
DE
$170B
$1.26M 0.15%
2,153
+119
+6% +$55.8K
HUBS icon
175
HubSpot
HUBS
$10.5B
$1.24M 0.15%
+3,091
New +$1.28M

Similar funds

FORA Capital's Q4 2025 Portfolio in Review

As of Q4 2025, FORA Capital held 687 positions worth $827M, up 46% from $566M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

FORA Capital deployed $286M of net new capital in Q4 2025, opening 231 new positions and adding to 120 existing holdings. Its largest new stake was Netflix: 148,006 shares worth $13.9M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Astera Labs, an estimated $5.36M trimmed.

  • FORA Capital's largest Q4 2025 buy was Netflix: 148,006 shares worth $13.9M.
  • FORA Capital added most to Roblox in Q4 2025, an estimated $12.4M increase.
  • FORA Capital's biggest Q4 2025 reduction was Astera Labs, cutting an estimated $5.36M.
  • FORA Capital fully exited NVIDIA in Q4 2025, selling an estimated $12.4M.
  • FORA Capital's ten largest holdings make up 16% of its $827M portfolio in Q4 2025.
  • FORA Capital opened 231 new positions and closed 276 in Q4 2025.
  • FORA Capital's portfolio value rose 46% quarter-over-quarter to $827M.

Based on FORA Capital's 13F filing for Q4 2025, filed 13 Feb 2026.